How AI-Powered RWE Is Cutting Drug Costs & Accelerating Development
From MEDDDICAL podcasts
Show by MEDDDICAL
Discover how real-world evidence is cutting drug development costs and accelerating timelines dramatically. Our experts unpack the AI revolution in RWE, regulatory acceptance, and why your strategy needs to start now. Read more at https://medddical.com/
More episodes of MEDDDICAL podcasts
More episodes
- Half the Story Was Always Missing: What Real-World Patient Data Changes Now
- Why Are Pharma Companies Investing in Insurance Claims Data & Real-World Data?
- Phenotype Validation in Real-World Data: Why It Makes or Breaks Your Study
- Longitudinal RWE in Pharma: What Makes a Dataset Fit for Purpose?
- What It Takes to Build Predictive Models That Actually Work
- Real-World Pharma Data: How It's Reshaping Modern Drug Development
- AI Synthetic Health Data: What Works for Pharma & What Doesn't
- Claims Data or EHR? How to Choose the Right Source for Your Study
- Which German Claims Data Route Is Right for Pharma? FDZ vs. Commercial Providers
- AI In RWE: How Choosing The Wrong Dataset Can Result In Clinical Disasters
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.